title: Alternol inhibits proliferation and induces apoptosis in mouse lymphocyte leukemia (L1210) cells.
abstract: Alternol is a novel compound purified from the fermenting products by microorganisms named as Alternaria alternata var. monosporus from the bark of Yew. In this study, we tested its effect on mouse lymphocyte leukemia L1210 cells. Alternol was found to inhibit the proliferation and induce apoptosis in L1210 cells. When the cells were treated with Alternol, chromatin condensation and phosphatidylserine externalization were observed with the down-regulation of the pro-survival gene Bcl-2 and the activation of caspase-3, caspase-9, but not caspase-8. Moreover, exposure of cells to Alternol resulted in a significant increase in reactive oxygen species (ROS) and mitochondrial transmembrane potential (DeltaPsim) depolarization. Taken together, these results demonstrate that Alternol is a potent agent in inducing L1210 cells to apoptosis, which involve caspase activation and ROS generation.
authors: Department of Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100083, PR China.
authors: Zhao-Zhe
authors: ZZ
authors: Liu
authors: Jin
authors: J
authors: Zhu
authors: Bo
authors: B
authors: Sun
authors: Shu
authors: S
authors: Liu
authors: Shuo
authors: S
authors: Geng
authors: Xia
authors: X
authors: Liu
authors: Chang-Ling
authors: CL
authors: Li
mesh_terms: D000528:Alternaria / Q000737:chemistry; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D015153:Blotting, Western; D053148:Caspase 3 / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D053453:Caspase 9 / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D005434:Flow Cytometry; D006576:Heterocyclic Compounds, 4 or More Rings / Q000494:pharmacology*; D007939:Leukemia L1210 / Q000378:metabolism / Q000473:pathology*; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D051379:Mice; D015394:Molecular Structure; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: C526095:Alternol; D000970:Antineoplastic Agents; D006576:Heterocyclic Compounds, 4 or More Rings; D019253:Proto-Oncogene Proteins c-bcl-2; D017382:Reactive Oxygen Species; D053148:Caspase 3; D053181:Caspase 8; D053453:Caspase 9
references: Apoptosis. 2003 Dec;8(6):617-29
references: 14739607
references: Cell. 1993 Aug 27;74(4):597-608
references: 8358789
references: Apoptosis. 2000 Jun;5(3):265-75
references: 11225848
references: Cancer Lett. 2001 Nov 8;173(1):53-61
references: 11578809
references: Cell. 1996 Jul 12;86(1):147-57
references: 8689682
references: Trends Cell Biol. 2000 Sep;10(9):369-77
references: 10932094
references: Circ Res. 2003 Oct 17;93(8):697-9
references: 14512440
references: Leukemia. 1993 Apr;7(4):563-8
references: 8096557
references: Mol Cell. 2002 Mar;9(3):459-70
references: 11931755
references: Biochem Pharmacol. 1999 Feb 1;57(3):231-45
references: 9890550
references: Biochem Soc Symp. 1999;66:167-79
references: 10989666
references: Exp Neurol. 1999 Sep;159(1):309-18
references: 10486199
references: Cell. 2004 Jan 23;116(2):205-19
references: 14744432
references: Science. 1995 Mar 10;267(5203):1456-62
references: 7878464
references: Science. 1991 Jul 5;253(5015):49-53
references: 1905840
references: Genes Dev. 2001 Nov 15;15(22):2922-33
references: 11711427
references: J Bacteriol. 2003 May;185(9):2683-6
references: 12700245
references: Nat Med. 2000 May;6(5):513-9
references: 10802706
references: Science. 2000 Mar 10;287(5459):1824-7
references: 10710310
references: Apoptosis. 2002 Aug;7(4):313-9
references: 12101390
references: Cell Death Differ. 2002 Oct;9(10):1031-42
references: 12232790
references: Nat Med. 1996 Jan;2(1):72-9
references: 8564846
references: Leukemia. 2004 Apr;18(4):817-25
references: 14990975
references: Blood. 1993 Nov 15;82(10):3133-40
references: 8219202
references: Redox Rep. 2001;6(6):351-62
references: 11865975
references: Chem Res Toxicol. 2001 Mar;14(3):243-63
references: 11258974
references: Curr Opin Genet Dev. 1996 Feb;6(1):45-9
references: 8791486
references: Clin Exp Med. 2003 May;3(1):4-14
references: 12748873
references: Nat Rev Cancer. 2002 Sep;2(9):647-56
references: 12209154
references: Brain Res. 2004 Mar 5;999(2):149-54
references: 14759493
references: Clin Chim Acta. 2005 Sep;359(1-2):89-100
references: 15922998
references: Blood Cells Mol Dis. 2003 Jul-Aug;31(1):63-71
references: 12850486
references: Oncogene. 1999 Nov 1;18(45):6145-57
references: 10557106
references: Anticancer Drugs. 1994 Feb;5(1):3-9
references: 8186426
references: Trends Pharmacol Sci. 1992 Apr;13(4):134-6
references: 1350385
references: J Cell Biochem. 2003 May 15;89(2):335-47
references: 12704796
references: Cancer Lett. 2007 Jan 8;245(1-2):341-9
references: 16517063
references: Biochem J. 1997 Aug 15;326 ( Pt 1):1-16
references: 9337844